THE IPI - Multibasket Trial in Advanced Melanoma: Prospective Clinical Phase II Multibasket Study in Melanoma Patients With Advanced Disease (DeCOG MM-PAL11).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2015
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 03 Jun 2014 Interim results (n=156) presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 17 Sep 2012 Planned end date changed from 1 Mar 2014 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 17 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.